Morgan Stanley Just Cut Juno Therapeutics' Price Target By: Benzinga via Benzinga June 30, 2015 at 15:42 PM EDT Shares of Juno Therapeutics Inc (NASDAQ: JUNO) surged on Tuesday, after the company announced a decade-long collaboration agreement ... Read More >> Related Stocks: Celgene Corp